Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (PALISADE-4)
Trial details
- Registry ID
- NCT06615557
- Phase
- Phase 3
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (PALISADE-4)NCT06615557 | VTGN | Phase 3 | Completed | 2026-04-21Actual |
| Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (PALISADE-3)NCT06358651 | VTGN | Phase 3 | Completed | 2025-10-31Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |